FDA Inspection 1119189 - Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy - February 20, 2020
FDA Inspection 1119189 for Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy on February 20, 2020. Classification: Official Action Indicated (OAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1119189 for Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy on February 20, 2020. Classification: Official Action Indicated (OAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
February 20, 2020
Product Type
Drugs
ID: 79c384ba-cdbb-48a3-8155-65af9c4e29a2
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox